Zydus to acquire stake in Mylab firm for 106 cr
Zydus Lifesciences announced that it will acquire a 6.5% stake in diagnostic firm Mylab Discovery Solutions for Rs 106 crore. Zydus Animal Health, a subsidiary...
Continue ReadingZydus Lifesciences announced that it will acquire a 6.5% stake in diagnostic firm Mylab Discovery Solutions for Rs 106 crore. Zydus Animal Health, a subsidiary...
Continue ReadingWhat are the digital health offerings the company has at present in the Indian market?LDH, a wholly-owned subsidiary of Lupin, has recently unveiled its digital...
Continue ReadingDr. Reddy’s Laboratories Limited (the “Company”) has entered into a Security Subscription and Shareholders’ Agreement for consumption and supply of renewable energy, with TEQ Green...
Continue ReadingBiocon Biologics said it has completed the integration of the acquired biosimilars business from Viatris Inc in over 70 countries in emerging markets effective July...
Continue ReadingForaying into the child nutrition segment, drug maker Dr. Reddy’s Laboratories launched CeleHealth Kidz Immuno Plus Gummies in the Indian market on other day. The...
Continue ReadingAurobindo Pharma subsidiary CuraTeQ Biologics has entered into an exclusive license agreement with U.S. firm BioFactura Inc to commercialise BFI-751, a proposed biosimilar to recombinant...
Continue ReadingPharmaceutical company, Dr Reddy’s Laboratories, announced that it is entering into the trade generics business in India with the launch of its new division, ‘RGenX’....
Continue ReadingGranules India Limited, a pharmaceutical company, has completed the U.S. Food and Drug Administration’s (US FDA) Pre-Approval Inspection (PAI) and GMP audit for their Unit...
Continue ReadingAurobindo Pharma Limited (along with its subsidiaries together referred to as “Aurobindo”) announced that the breast cancer biosimilar product, BP02 (Trastuzumab or biosimilar to Herceptin),...
Continue Reading